Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genetically Modified Stem Cells are Effective Against Acute Respiratory Diseases

Published: Tuesday, June 18, 2013
Last Updated: Tuesday, June 18, 2013
Bookmark and Share
Administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury.

Study results were published in the American Journal of Respiratory Cell and Molecular Biology.

Acute lung injury

Acute lung injury and its more severe manifestation, the acute respiratory distress syndrome, are characterized by very severe inflammatory processes that damage the lungs with a mortality of between 40% and 50%. Currently there is no effective treatment beyond palliative care and mechanical assistance to breath.

"In the last years we have been working in the administration of human mesenchymal stem cells from adipose tissue obtained from liposuction in different pathologies," said the researcher of Human Molecular Genetics reserach group at IDIBELL Josep Maria Aran. "We have found that these stem cells are able to easily reach the lungs and there, secrete anti-inflammatory substances and growth factors."

Alarm signal

The studies conducted so far with these cells have shown a positive effect. IDIBELL and VHIR researchers have introduced a genetic modification in these cells that improves treatment.

The cytokine IL33 is a protein that acts as an alarm signal in these patients. When the damage into the lungs begins, the cells secrete this highly proinflammatory substance and elicit a very strong immune system answer.

"We believed," says Aran, "that if we modified genetically mesenchymal stem cells to secrete a molecule antagonist of IL-33, we could stop the inflammatory process and we found that, in mice, the effect was more positive than unmodified cells: regeneration of lung tissue and practically nullifies the inflammatory process in the lungs. "

IDIBELL has signed a licensing agreement with the Basque company Histocell for this genetic modification and currently they are working to make this "smart drug" may reach the clinical stage and try to patients.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

IDIBELL and VHIR licenses Histocell a Patent for Acute Respiratory Diseases with Stem Cells
It is a "smart drug" that can reduce inflammation and regenerate damaged tissue.
Tuesday, April 09, 2013
IDIBELL Licenses Histocell a Patent for Acute Respiratory Diseases with Stem Cells
It is a "smart drug" that can reduce inflammation and regenerate damaged tissue.
Wednesday, April 03, 2013
IDIBELL licenses Histocell a Patent for Acute Respiratory Diseases with Stem Cells
It is a "smart drug" that can reduce inflammation and regenerate damaged tissue.
Wednesday, March 27, 2013
Scientific News
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Stem Cells Growing 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Stem Cell Transplant Without Radiation or Chemotherapy
Researchers have successfully performed stem cell transplants without using radiation or chemotherapy.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
Inherited Heart Condition Breakthrough
Using stem cells, scientists have created a specific heart condition model, yeilding insights into unexpected disease mechanisms.
Biobank Storage Time Affects Blood Test Results
Study finds storage time of blood samples at a biobank may affect test results as much as patient age.
Transplanted Stem Cells Age Cells by 30 Years
Research suggests stem cell transplants are linked to an increase in immune cell's “molecular age” from blood cancer patients.
Commanding Stem Cells to Build Bone
Natural molecule can coax stem cells into regenerating bone tissue, researchers have discovered.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!